Skip to main content
Signal8

Elixxer Ltd. (ELIXF)

Sector: Drug Manufacturers - Specialty & Generic

Industry: Drug Manufacturers - Specialty & Generic

Elixxer Ltd. logo

Elixxer Ltd.

OTC:ELIXFHealthcare
CLOSED
Mkt Cap$3.19M
EV-
Float14.68M
O/S95.26M
VOL714 sh
Inst Own-
SI0.1%
Net Cash/Sh-
Dilution
Historical Data
DateOpenHighLowCloseVolume
Oct 6, 20260.00010.00010.00000.0000714
Analyst Coverage
No analyst coverage for this companyNo ratings, price targets, or covering firms on file.
About

Elixxer Ltd. operates as an investment company specifically focused on the cannabis industry. This firm strategically deploys capital into fully licensed businesses engaged in the cultivation, production, and sale of medicinal and specialized cannabis, as well as cannabis-derived products, predominantly for the pharmaceutical sector.

Its investment reach extends across Canada, Australia, Italy, Jamaica, and Switzerland. Founded in 2004, the Montreal, Canada-based company adopted its current name, Elixxer Ltd., in August 2019, having previously been known as LGC Capital Ltd.

Key Metrics
Market Cap$3.19M
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership--

based on 95.26M shares outstanding

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ExchangeOTC
CountryCACA
IPO Date-
Shares Outstanding95.26M
Authorized Shares
Float14.68M
52-Week Range
Volume
Average Daily Volume--

30d Avg

--

60d Avg

714

90d Avg

714

Earnings
Dividend History
No dividend history available